Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
August 15, 2024
These three stocks to buy now will protect your portfolio if the S&P 500 crashes again regardless of whether there is a recession or not.
Via
InvestorPlace
Topics
Economy
Stocks
Exposures
Economy
US Equities
Decoding AbbVie's Options Activity: What's the Big Picture?
August 14, 2024
Via
Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demonstrating superiority. The trial evaluated tamibarotene with venetoclax and...
Via
Benzinga
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
August 12, 2024
Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%.
Via
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
August 02, 2024
Via
Benzinga
A Closer Look at AbbVie's Options Market Dynamics
July 31, 2024
Via
Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
All of these stocks can provide steady income to retired investors.
Via
The Motley Fool
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions.
Via
Benzinga
Elliott Wave Technical Analysis: AbbVie Inc.
August 07, 2024
An in-depth look at ABBV's price movements using the Elliott Wave Theory, helping traders identify potential opportunities based on current trends and market structure.
Via
Talk Markets
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
Via
Benzinga
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Healthcare and biopharma show nice gains in a volatile week.
Via
Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts.
Via
The Motley Fool
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early
July 31, 2024
The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.
Via
Investor's Business Daily
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
July 31, 2024
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates.
Via
InvestorPlace
7 Stocks Set for a Major Bull Run
July 31, 2024
Explore top stocks to buy, leading in social media, semiconductors, entertainment, restaurants, payments and biotechnology.
Via
InvestorPlace
3 Powerhouse Growth Stocks to Load Up On During This Bull Market Cycle
July 31, 2024
Here are three powerhouse growth stocks long-term investors may want to hone in on during this part of the market cycle.
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns.
Via
Benzinga
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.
Via
InvestorPlace
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
July 29, 2024
Passive income and ETFs represent two compelling market concepts. Why not bring the two together with dividend-paying ETFs?
Via
InvestorPlace
Topics
ETFs
AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations
July 26, 2024
AbbVie reports Q2 earnings with adjusted EPS of $2.65, surpassing expectations. Net revenues hit $14.46 billion, reflecting a 4.3% increase. Analysts maintain a positive outlook with increased price...
Via
Benzinga
Lockheed Martin To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
July 26, 2024
Via
Benzinga
Why AbbVie Stock Was Cruising Higher on Thursday
July 25, 2024
The market was impressed with a notable increase in full-year guidance.
Via
The Motley Fool
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
July 25, 2024
ABBV earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
July 25, 2024
Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown.
Via
Benzinga
Topics
Economy
Exposures
Economy
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024
July 25, 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today
July 25, 2024
AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.
Via
InvestorPlace
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
July 25, 2024
AbbVie Inc. reported Q2 adjusted EPS of $2.65, beating the $2.57 consensus, with net revenues at $14.46 billion. Immunology sales rose to $6.97 billion, while Humira declined 29.8%. Oncology and...
Via
Benzinga
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.